Annual Review of Cancer Biology
| 短名 | Annu. Rev. Cancer Biol. |
| Journal Impact | 4.58 |
| 国际分区 | ONCOLOGY(Q1) |
| 期刊索引 | SCI Q1中科院 2 区 |
| ISSN | 2472-3428 |
| h-index | 36 |
| 国内分区 | 医学(2区)医学肿瘤学(2区) |
| 涉及主题 | 生物遗传学医学内科学癌症化学生物化学基因癌症研究细胞生物学免疫学计算生物学免疫系统病理生物信息学物理 |
| 出版信息 | 出版商: Annual Reviews Inc.，出版周期: ，期刊类型: book-series |
| 基本数据 | 创刊年份: 2022，原创研究文献占比: 0.00%，自引率:0.00%， Gold OA占比: 85.45% |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Applications of Digital Pathology in Cancer: A Comprehensive Review
2024-6-12
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?
2024-6-12
Next-Generation Therapies for Multiple Myeloma
2024-6-12
Small-Molecule Approaches to Target Transcription Factors
2024-6-12
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond
2024-6-12
Deciphering the Warburg Effect: Metabolic Reprogramming, Epigenetic Remodeling, and Cell Dedifferentiation
2024-6-12
Germline Predisposition to Hematopoietic Malignancies: An Overview
2024-6-12
Relationships Between Regeneration, Wound Healing, and Cancer
2024-6-12
Biological, Diagnostic, and Therapeutic Insights from (Epi)Genomic Profiling of Pediatric Brain Tumors
2024-6-12
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer
2024-6-12
RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations
2024-6-12
Mechanisms of Resistance to Targeted Therapies in AML
2024-6-12
Metabolic Rewiring During Metastasis: The Interplay Between the Environment and the Host
2024-6-12
Chemical Proteomics–Guided Discovery of Covalent Ligands for Cancer Proteins
2024-6-12
Allogeneic CAR T Cell Therapy for Cancer
2024-6-12
Histone H3 Variants in the Multiverse of Cancer
2024-6-12
Extrachromosomal DNA: Biogenesis and Functions in Cancer
2024-6-12
Complex Roles of PTPN11/SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy
2024-6-12
Basket Trials: Past, Present, and Future
2024-6-12
Studying Progression from Chronic Injury to Esophageal Adenocarcinoma
2024-6-12
An Erratic Path Toward Discovery
2024-6-12
The Intestinal Microbiota and Therapeutic Responses to Immunotherapy
2024-1-25
Therapeutic Targeting of the Menin–KMT2A Interaction
2024-1-2
Biological, Diagnostic, and Therapeutic Insights from (Epi)Genomic Profiling of Pediatric Brain Tumors
2023-12-18
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond
2023-12-6
The Blood-Brain Barrier: Implications for Experimental Cancer Therapeutics
2023-4-11
Reinventing Radiobiology in the Light of FLASH Radiotherapy
2023-4-11
The Potent and Paradoxical Biology of Cellular Senescence in Cancer
2023-4-11
CAR NK Cells: The Future Is Now
2023-4-11
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies
2023-4-11
The Role of Phase-Separated Condensates in Fusion Oncoprotein–Driven Cancers
2023-4-11
Engineering the Immune Microenvironment into Organoid Models
2023-4-11
Cancer-Associated Fibroblasts: Lessons from Pancreatic Cancer
2023-4-11
AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?
2023-4-11
New Tools for Lineage Tracing in Cancer In Vivo
2023-4-11
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy
2023-4-11
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance
2023-4-11
Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor–Based Cellular Therapy
2023-1-25
On the Biology and Therapeutic Modulation of Macrophages and Dendritic Cells in Cancer
2023-1-25
Next-Generation Estrogen Receptor–Targeted Therapeutics
2023-1-25
Somatic Mutations in Normal Tissues: New Perspectives on Early Carcinogenesis
2023-1-17
Immune Cell Metabolism and Immuno-Oncology
2023-1-17
Strategies for Heating Up Cold Tumors to Boost Immunotherapies
2023-1-17
Targeting KRAS G12C with Covalent Inhibitors
2022-4-11
Targeting BET Bromodomains in Cancer
2022-4-11
<i>RB1</i>, Cancer Lineage Plasticity, and Therapeutic Resistance
2022-4-11
TGFβ: Signaling Blockade for Cancer Immunotherapy
2022-4-11
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远